Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Non-small Cell Lung Cancer × necitumumab × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Squamous Non Small Cell Lung Cancer 1 Non-small Cell Lung Cancer Metastatic 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Paclitaxel 2 Carboplatin 2 tremelimumab 1 pembrolizumab 1 necitumumab 1 envafolimab 1 durvalumab 1 Nivolumab 1 Gemcitabine 1 Endostatins 1 Drug Therapy 1 Cisplatin 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01763788 2019-10-25

A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)

Eli Lilly and Company

Phase 1/2 Completed

192 enrolled 24 charts

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡